XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Financial Assets & Liabilities (Tables)
9 Months Ended
Sep. 30, 2021
Financial Assets & Liabilities  
Financial assets and financial liabilities measured at fair value on a recurring basis

Fair Value

Hierarchy

At September 30, 2021

At December 31, 2020

(Dollars in millions)

    

Level

    

Assets (7)

    

Liabilities (8)

    

Assets (7)

    

Liabilities (8)

Cash equivalents: (1)

Time deposits and certificates of deposit (2)

2

$

3,030

$

N/A

$

7,668

$

N/A

Money market funds

1

130

N/A

148

N/A

U.S. government securities (2)

2

N/A

500

N/A

Total cash equivalents

$

3,160

$

N/A

$

8,316

$

N/A

Equity investments (3)

1

0

N/A

2

N/A

Debt securities-current (2)(4)

2

600

N/A

600

N/A

Debt securities-noncurrent (2)(5)

2

6

N/A

7

N/A

Derivatives designated as hedging instruments:

Interest rate contracts

2

16

100

Foreign exchange contracts

2

367

95

111

580

Derivatives not designated as hedging instruments:

Foreign exchange contracts

2

42

38

13

47

Equity contracts (6)

1,2

16

12

Total

$

4,191

$

149

$

9,161

$

627

(1)Included within cash and cash equivalents in the Consolidated Balance Sheet.
(2)Available-for-sale debt securities with carrying values that approximate fair value.
(3)Included within investments and sundry assets in the Consolidated Balance Sheet.
(4)U.S. treasury bills that are reported within marketable securities in the Consolidated Balance Sheet.
(5)Primarily includes government debt securities that are reported within investments and sundry assets in the Consolidated Balance Sheet.
(6)Level 1 includes immaterial amounts related to equity futures contracts.
(7)The gross balances of derivative assets contained within prepaid expenses and other current assets, and investments and sundry assets in the Consolidated Balance Sheet at September 30, 2021 were $373 million and $52 million, respectively, and at December 31, 2020 were $85 million and $151 million, respectively.
(8)The gross balances of derivative liabilities contained within other accrued expenses and liabilities, and other liabilities in the Consolidated Balance Sheet at September 30, 2021 were $69 million and $80 million, respectively, and at December 31, 2020 were $587 million and $40 million, respectively.